(ODD) ODDITY Tech Ordinary Shares - Overview
Exchange: NASDAQ •
Country: Israel •
Currency: USD •
Type: Common Stock •
ISIN: IL0011974909
Stock: Cosmetics, Skincare, Haircare, Supplements
Total Rating 27
Risk 99
Buy Signal -0.68
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 51.1% |
| Relative Tail Risk | -10.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.44 |
| Alpha | -55.97 |
| Character TTM | |
|---|---|
| Beta | 1.286 |
| Beta Downside | 1.215 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.81% |
| CAGR/Max DD | -0.26 |
Description: ODD ODDITY Tech Ordinary Shares January 10, 2026
Oddity Tech Ltd. (NASDAQ: ODD) is a Tel-Aviv-based consumer-tech firm that creates and markets digital-first beauty and wellness brands, primarily in the United States and select international markets.
The company’s AI-driven platform leverages data science, machine-learning, and computer-vision to surface consumer demand signals and translate them into product assortments across makeup, skincare, haircare, and supplements under the IL MAKIAGE and SpoiledChild labels. A dedicated R&D unit, ODDITY LABS, uses AI-based molecule discovery to generate proprietary ingredients for its product pipeline.
Key performance indicators from recent filings show a year-over-year revenue increase of roughly 45 % and a gross margin expansion to 62 %, reflecting both higher-margin proprietary formulations and scaling of its e-commerce infrastructure. The broader “beauty-tech” sector is projected to grow at a CAGR of 12 % through 2028, driven by consumer willingness to adopt personalized, data-informed products and by rising online beauty spend post-pandemic.
For a deeper quantitative assessment, you might explore ValueRay’s analytics platform to benchmark ODD’s valuation against sector peers.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 110.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -2.73 > 1.0 |
| NWC/Revenue: 87.38% < 20% (prev 21.69%; Δ 65.69% < -1%) |
| CFO/TA 0.10 > 3% & CFO 108.7m > Net Income 110.2m |
| Net Debt (-568.2m) to EBITDA (140.5m): -4.04 < 3 |
| Current Ratio: 7.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (62.7m) vs 12m ago 1.47% < -2% |
| Gross Margin: 73.13% > 18% (prev 0.72%; Δ 7241 % > 0.5%) |
| Asset Turnover: 96.69% > 50% (prev 122.7%; Δ -26.02% > 0%) |
| Interest Coverage Ratio: 1709 > 6 (EBITDA TTM 140.5m / Interest Expense TTM 76.0k) |
Altman Z'' 6.47
| A: 0.62 (Total Current Assets 786.6m - Total Current Liabilities 104.4m) / Total Assets 1.11b |
| B: 0.28 (Retained Earnings 308.1m / Total Assets 1.11b) |
| C: 0.16 (EBIT TTM 129.9m / Avg Total Assets 807.5m) |
| D: 0.43 (Book Value of Equity 312.4m / Total Liabilities 728.5m) |
| Altman-Z'' Score: 6.47 = AAA |
Beneish M -3.33
| DSRI: 0.70 (Receivables 9.49m/10.8m, Revenue 780.8m/620.6m) |
| GMI: 0.98 (GM 73.13% / 71.85%) |
| AQI: 0.62 (AQ_t 0.26 / AQ_t-1 0.42) |
| SGI: 1.26 (Revenue 780.8m / 620.6m) |
| TATA: 0.00 (NI 110.2m - CFO 108.7m) / TA 1.11b) |
| Beneish M-Score: -3.33 (Cap -4..+1) = AA |
What is the price of ODD shares?
As of February 07, 2026, the stock is trading at USD 30.07 with a total of 720,008 shares traded.
Over the past week, the price has changed by -8.43%, over one month by -23.54%, over three months by -24.75% and over the past year by -35.75%.
Over the past week, the price has changed by -8.43%, over one month by -23.54%, over three months by -24.75% and over the past year by -35.75%.
Is ODD a buy, sell or hold?
ODDITY Tech Ordinary Shares has received a consensus analysts rating of 4.11.
Therefore, it is recommended to buy ODD.
- StrongBuy: 4
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ODD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 62 | 106.2% |
| Analysts Target Price | 62 | 106.2% |
| ValueRay Target Price | 25.7 | -14.5% |
ODD Fundamental Data Overview February 03, 2026
P/E Trailing = 18.3464
P/S = 2.416
P/B = 4.955
Revenue TTM = 780.8m USD
EBIT TTM = 129.9m USD
EBITDA TTM = 140.5m USD
Long Term Debt = 583.5m USD (from longTermDebt, last quarter)
Short Term Debt = 6.94m USD (from shortTermDebt, last quarter)
Debt = 23.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -568.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.27b USD (1.89b + Debt 23.8m - CCE 639.7m)
Interest Coverage Ratio = 1709 (Ebit TTM 129.9m / Interest Expense TTM 76.0k)
EV/FCF = 12.44x (Enterprise Value 1.27b / FCF TTM 102.1m)
FCF Yield = 8.04% (FCF TTM 102.1m / Enterprise Value 1.27b)
FCF Margin = 13.08% (FCF TTM 102.1m / Revenue TTM 780.8m)
Net Margin = 14.11% (Net Income TTM 110.2m / Revenue TTM 780.8m)
Gross Margin = 73.13% ((Revenue TTM 780.8m - Cost of Revenue TTM 209.8m) / Revenue TTM)
Gross Margin QoQ = 71.59% (prev 72.30%)
Tobins Q-Ratio = 1.15 (Enterprise Value 1.27b / Total Assets 1.11b)
Interest Expense / Debt = 0.32% (Interest Expense 76.0k / Debt 23.8m)
Taxrate = 24.68% (5.82m / 23.6m)
NOPAT = 97.8m (EBIT 129.9m * (1 - 24.68%))
Current Ratio = 7.54 (Total Current Assets 786.6m / Total Current Liabilities 104.4m)
Debt / Equity = 0.06 (Debt 23.8m / totalStockholderEquity, last quarter 380.7m)
Debt / EBITDA = -4.04 (Net Debt -568.2m / EBITDA 140.5m)
Debt / FCF = -5.56 (Net Debt -568.2m / FCF TTM 102.1m)
Total Stockholder Equity = 336.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.64% (Net Income 110.2m / Total Assets 1.11b)
RoE = 32.79% (Net Income TTM 110.2m / Total Stockholder Equity 336.0m)
RoCE = 14.12% (EBIT 129.9m / Capital Employed (Equity 336.0m + L.T.Debt 583.5m))
RoIC = 15.59% (NOPAT 97.8m / Invested Capital 627.5m)
WACC = 10.53% (E(1.89b)/V(1.91b) * Re(10.66%) + D(23.8m)/V(1.91b) * Rd(0.32%) * (1-Tc(0.25)))
Discount Rate = 10.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.97%
[DCF Debug] Terminal Value 73.49% ; FCFF base≈85.4m ; Y1≈105.4m ; Y5≈179.4m
Fair Price DCF = 55.87 (EV 2.00b - Net Debt -568.2m = Equity 2.56b / Shares 45.9m; r=10.53% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -4.29 | EPS CAGR: -57.56% | SUE: -2.40 | # QB: 0
Revenue Correlation: 67.85 | Revenue CAGR: 15.10% | SUE: 0.69 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.43 | Chg30d=+0.005 | Revisions Net=+1 | Analysts=7
EPS next Year (2026-12-31): EPS=2.40 | Chg30d=+0.016 | Revisions Net=+1 | Growth EPS=+12.2% | Growth Revenue=+20.6%
P/S = 2.416
P/B = 4.955
Revenue TTM = 780.8m USD
EBIT TTM = 129.9m USD
EBITDA TTM = 140.5m USD
Long Term Debt = 583.5m USD (from longTermDebt, last quarter)
Short Term Debt = 6.94m USD (from shortTermDebt, last quarter)
Debt = 23.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -568.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.27b USD (1.89b + Debt 23.8m - CCE 639.7m)
Interest Coverage Ratio = 1709 (Ebit TTM 129.9m / Interest Expense TTM 76.0k)
EV/FCF = 12.44x (Enterprise Value 1.27b / FCF TTM 102.1m)
FCF Yield = 8.04% (FCF TTM 102.1m / Enterprise Value 1.27b)
FCF Margin = 13.08% (FCF TTM 102.1m / Revenue TTM 780.8m)
Net Margin = 14.11% (Net Income TTM 110.2m / Revenue TTM 780.8m)
Gross Margin = 73.13% ((Revenue TTM 780.8m - Cost of Revenue TTM 209.8m) / Revenue TTM)
Gross Margin QoQ = 71.59% (prev 72.30%)
Tobins Q-Ratio = 1.15 (Enterprise Value 1.27b / Total Assets 1.11b)
Interest Expense / Debt = 0.32% (Interest Expense 76.0k / Debt 23.8m)
Taxrate = 24.68% (5.82m / 23.6m)
NOPAT = 97.8m (EBIT 129.9m * (1 - 24.68%))
Current Ratio = 7.54 (Total Current Assets 786.6m / Total Current Liabilities 104.4m)
Debt / Equity = 0.06 (Debt 23.8m / totalStockholderEquity, last quarter 380.7m)
Debt / EBITDA = -4.04 (Net Debt -568.2m / EBITDA 140.5m)
Debt / FCF = -5.56 (Net Debt -568.2m / FCF TTM 102.1m)
Total Stockholder Equity = 336.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.64% (Net Income 110.2m / Total Assets 1.11b)
RoE = 32.79% (Net Income TTM 110.2m / Total Stockholder Equity 336.0m)
RoCE = 14.12% (EBIT 129.9m / Capital Employed (Equity 336.0m + L.T.Debt 583.5m))
RoIC = 15.59% (NOPAT 97.8m / Invested Capital 627.5m)
WACC = 10.53% (E(1.89b)/V(1.91b) * Re(10.66%) + D(23.8m)/V(1.91b) * Rd(0.32%) * (1-Tc(0.25)))
Discount Rate = 10.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.97%
[DCF Debug] Terminal Value 73.49% ; FCFF base≈85.4m ; Y1≈105.4m ; Y5≈179.4m
Fair Price DCF = 55.87 (EV 2.00b - Net Debt -568.2m = Equity 2.56b / Shares 45.9m; r=10.53% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -4.29 | EPS CAGR: -57.56% | SUE: -2.40 | # QB: 0
Revenue Correlation: 67.85 | Revenue CAGR: 15.10% | SUE: 0.69 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.43 | Chg30d=+0.005 | Revisions Net=+1 | Analysts=7
EPS next Year (2026-12-31): EPS=2.40 | Chg30d=+0.016 | Revisions Net=+1 | Growth EPS=+12.2% | Growth Revenue=+20.6%